BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/17/2021 6:19:34 AM | Browse: 871 | Download: 2059
 |
Received |
|
2020-11-08 08:56 |
|
Peer-Review Started |
|
2020-11-01 11:08 |
|
First Decision by Editorial Office Director |
|
2020-11-30 02:01 |
|
Return for Revision |
|
2020-11-30 02:01 |
|
Revised |
|
2021-01-11 03:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-03-02 08:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-03-08 03:11 |
|
Articles in Press |
|
2021-03-08 03:11 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-03-16 06:34 |
|
Publish the Manuscript Online |
|
2021-03-17 06:19 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Waled Mohsen, Astrid-Jane Williams, Gabrielle Wark, Alexandra Sechi, Jenn-Hian Koo, Wei Xuan, Milan Bassan, Watson Ng and Susan Connor |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Waled Mohsen, FACP, Doctor, Doctor, Liverpool Hospital , AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital Missenden, Road Camperdown, Bigge Street Liverpool, Sydney 2170, Queensland, Australia. wmoh6298@uni.sydney.edu.au |
| Key Words |
Bowel preparation; Inflammatory Bowel Disease; Tolerability; Efficacy; Moviprep; Prep Kit-C |
| Core Tip |
When comparing Moviprep (Mp) and Prep-Kit C in patients with and without inflammatory bowel disease (IBD): (1) Efficacy, tolerability and safety of Mp and Prep-Kit C are similar; (2) Participants with IBD reported lower tolerability with both preparations; (3) IBD participants described more abdominal pain with Mp. Consideration of these results are important when discussing bowel preparation with IBD patients. |
| Publish Date |
2021-03-17 06:19 |
| Citation |
Mohsen W, Williams AJ, Wark G, Sechi A, Koo JH, Xuan W, Bassan M, Ng W, Connor S. Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy? World J Gastroenterol 2021; 27(11): 1090-1100 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i11/1090.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i11.1090 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
